Seroprevalence of HCV and its co-infection with HBV and HIV among liver disease patients of South Tamil Nadu

World Journal of Hepatology

Volumn 2, Issue 1, 2010, Pages 42-48

  Anbazhagan, Ganesh Kumar ^a   Krishnamoorthy, Sridharan ^a,b   Thiyagarajan, Thirunalasundari ^a  

^a BHARATHIDASAN UNIVERSITY   (India)

^b KAP Viswanathan Medical College   (India)

Author keywords

Co infection; Hepatitis B virus; Hepatitis C virus; Human immunodeficiency virus; Liver function test

Indexed keywords

EID: 79955940016     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v2.i1.42     Document Type: Article

References (50)

1. Gasiorowicz M, Hurie M, Russell A, Hoxie N, Vergeront J. Epidemiologic trends in infection, mortality, and transplants related to hepatitis C in Wisconsin. WMJ 2006; 105: 34-39
2. Alter HJ, Seeff LB. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin Liver Dis 2000; 20: 17-35
3. Sy T, Jamal MM. Epidemiology of hepatitis C virus (HCV) infection. Int J Med Sci 2006; 3: 41-46
4. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006; 28: 112-125
5. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007; 45: 507-539
6. Liu Z, Hou J. Hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection. Int J Med Sci 2006; 3: 57-62
7. Davis GL, Albright JE, Cook SF, Rosenberg DM. Projecting future complications of chronic hepatitis C in the United States. Liver Transpl 2003; 9: 331-338
8. Report on the Global AIDS Epidemic. Available from: URL: http://www.unaids.org/en/HIV_data/2006GlobalReport/default.asp. Accessed on 2007-10-06
9. Chung RT. Hepatitis C and B viruses: the new opportunists in HIV infection. Top HIV Med 2006; 14: 78-83
10. Alter MJ. Epidemiology of viral hepatitis and HIV coinfection. J Hepatol 2006; 44: S6-S9
11. Monica F, Lirussi F, Pregun I, Vasile F, Fabris L, Okolicsanyi L. Hepatitis C virus infection in a resident elderly population: a 10-year follow-up study. Dig Liver Dis 2006; 38: 336-340
12. Gaeta GB, Precone DF, Cozzi-Lepri A, Cicconi P, D'Arminio Monforte A. Multiple viral infections. J Hepatol 2006; 44: S108-S113
13. Chandra M, Khaja MN, Farees N, Poduri CD, Hussain MM, Aejaz Habeeb M, Habibullah CM. Prevalence, risk factors and genotype distribution of HCV and HBV infection in the tribal population: a community based study in south India. Trop Gastroenterol 2003; 24: 193-195
14. Chowdhury A, Santra A, Chaudhuri S, Dhali GK, Chaudhuri S, Maity SG, Naik TN, Bhattacharya SK, Mazumder DN. Hepatitis C virus infection in the general population: a community-based study in West Bengal, India. Hepatology 2003; 37: 802-809
15. Rivera-López MR, Zavala-Méndez C, Arenas-Esqueda A. [Prevalence for seropositivity for HIV, hepatitis B and hepatitis C in blood donors] Gac Med Mex 2004; 140: 657-660
16. Carreto-Vélez MA, Carrada-Bravo T, Martínez-Magdaleno A. [Seroprevalence of HBV, HCV, and HIV among blood donors in Irapuato, Mexico] Salud Publica Mex 2003; 45 Supp 5: S690-S693
17. Silva LK, Silva MB, Rodart IF, Lopes GB, Costa FQ, Melo ME, Gusmão E, Reis MG. Prevalence of hepatitis C virus (HCV) infection and HCV genotypes of hemodialysis patients in Salvador, Northeastern Brazil. Braz J Med Biol Res 2006; 39: 595-602
18. Soriano V, Barreiro P, Nuñez M. Management of chronic hepatitis B and C in HIV-coinfected patients. J Antimicrob Chemother 2006; 57: 815-818
19. Gunduz T, Mumcuoglu I, Güray M. Evaluation of hepatitis B surface antigen, anti-hepatitis C virus and antihuman immunodeficiency virus antibodies and syphilis seropositivity in blood donors: six years' seropositivity. Int J Clin Pharmacol Res 2005; 25: 155-158
20. National AIDS Control Organization (NACO). HIV/AIDS epidemiological Surveillance&Estimation report for the year 2005. Available from: URL: http://www.nacoonline.org/
21. Yachimski P, Chung RT. Update on Hepatitis B and C Coinfection in HIV. Curr Infect Dis Rep 2005; 7: 299-308
22. Schooley RT. HIV and hepatitis C virus coinfection: bad bedfellows. Top HIV Med 2005; 13: 112-116
23. Koch S, Göbels K, Oette M, Heintges T, Erhardt A, Häussinger D. [HIV-HBV-coinfection--diagnosis and therapy] Dtsch Med Wochenschr 2006; 131: 1873-1877
24. Murphy MJ. Managing HIV/HBV coinfection can challenge some clinicians. HIV Clin 2003; 15: 6-9
25. Chowdhury A, Santra A, Chaudhuri S, Dhali GK, Chaudhuri S, Maity SG, Naik TN, Bhattacharya SK, Mazumder DN. Hepatitis C virus infection in the general population: a community-based study in West Bengal, India. Hepatology 2003; 37: 802-809
26. Chen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci 2006; 3: 47-52
27. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144: 705-714
28. Sud A, Singh J, Dhiman RK, Wanchu A, Singh S, Chawla Y. Hepatitis B virus co-infection in HIV infected patients. Trop Gastroenterol 2001; 22: 90-92
29. Padmapriyadarsini C, Chandrabose J, Victor L, Hanna LE, Arunkumar N, Swaminathan S. Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function. J Postgrad Med 2006; 52: 92-96
30. Arora DR, Sehgal R, Gupta N, Yadav A, Mishra N, Siwach SB. Prevalence of parenterally transmitted hepatitis viruses in clinically diagnosed cases of hepatitis. Indian J Med Microbiol 2005; 23: 44-47
31. Gaeta GB, Stornaiuolo G, Precone DF, Lobello S, Chiaramonte M, Stroffolini T, Colucci G, Rizzetto M. Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study. J Hepatol 2003; 39: 1036-1041
32. Kumar A, Shukla I, Malik A. Co-infection with hepatitis B and human immunodeficiency viruses in patients of liver disease. Indian J Med Microbiol 2003; 21: 141-142
33. Shire NJ, Sherman KE. Management of HBV/HIV-coinfected Patients. Semin Liver Dis 2005; 25 Suppl 1: 48-57
34. Kumarasamy N, Solomon S, Flanigan TP, Hemalatha R, Thyagarajan SP, Mayer KH. Natural history of human immunodeficiency virus disease in southern India. Clin Infect Dis 2003; 36: 79-85
35. Bhattacharya S, Badrinath S, Hamide A, Sujatha S. Co-infection with hepatitis C virus and human immunodeficiency virus among patients with sexually transmitted diseases in Pondicherry, South India. Indian J Pathol Microbiol 2003; 46: 495-497
36. Hussain T, Kulshreshtha KK, Sinha S, Yadav VS, Katoch VM. HIV, HBV, HCV, and syphilis co-infections among patients attending the STD clinics of district hospitals in Northern India. Int J Infect Dis 2006; 10: 358-363
37. Gupta S, Singh S. Hepatitis B and C virus co-infections in human immunodeficiency virus positive North Indian patients. World J Gastroenterol 2006; 12: 6879-6883
38. Poudel KC, Jimba M, Okumura J, Wakai S. Emerging coinfection of HIV and hepatitis B virus in far western Nepal. Trop Doct 2006; 36: 186-187
39. Chandra M, Khaja MN, Farees N, Poduri CD, Hussain MM, Aejaz Habeeb M, Habibullah CM. Prevalence, risk factors and genotype distribution of HCV and HBV infection in the tribal population: a community based study in south India. Trop Gastroenterol 2003; 24: 193-195
40. Lascar RM, Gilson RJ, Lopes AR, Bertoletti A, Maini MK. Reconstitution of hepatitis B virus (HBV)-specific T cell responses with treatment of human immunodeficiency virus/HBV coinfection. J Infect Dis 2003; 188: 1815-1819
41. O'Leary JG, Chung RT. Management of hepatitis C virus coinfection in HIV-infected persons. AIDS Read 2006; 16: 313-316, 318-320
42. Greub G, Ledergerber B, Battegay M, Grob P, Perrin L, Furrer H, Burgisser P, Erb P, Boggian K, Piffaretti JC, Hirschel B, Janin P, Francioli P, Flepp M, Telenti A. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet 2000; 356: 1800-1805
43. Sulkowski MS, Moore RD, Mehta SH, Chaisson RE, Thomas DL. Hepatitis C and progression of HIV disease. JAMA 2002; 288: 199-206
44. Lincoln D, Petoumenos K, Dore GJ. HIV/HBV and HIV/ HCV coinfection, and outcomes following highly active antiretroviral therapy. HIV Med 2003; 4: 241-249
45. Anderson KB, Guest JL, Rimland D. Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta VA Cohort Study. Clin Infect Dis 2004; 39: 1507-1513
46. Law WP, Duncombe CJ, Mahanontharit A, Boyd MA, Ruxrungtham K, Lange JM, Phanuphak P, Cooper DA, Dore GJ. Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort. AIDS 2004; 18: 1169-1177
47. Rockstroh J, Konopnicki D, Soriano V, Krik O, Antunes F, Knysz B, Tural C, Wit SD, Mocroft A, Lundgren J. Hepatitis B and hepatitis C in the EuroSIDA Cohort: Prevalence and Effect on Mortality, AIDS Progression and Response to HAART. Eleventh conference on retroviruses and opportunistic infections 2004; abs 799
48. Rockstroh JK. Management of hepatitis B and C in HIV coinfected patients. J Acquir Immune Defic Syndr 2003; 34 Suppl 1: S59-S65
49. Tien PC. Management and treatment of hepatitis C virus infection in HIV-infected adults: recommendations from the Veterans Affairs Hepatitis C Resource Center Program and National Hepatitis C Program Office. Am J Gastroenterol 2005; 100: 2338-2354
50. Tankhiwale SS, Khadase RK, Jalgoankar SV. Seroprevalence of anti-HCV and hepatitis B surface antigen in HIV infected patients. Ind J Med Microbial 2003; 21: 268-270